GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 651 - 675 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G14569AR
3411
IgG Patient 3 11 mild
G14569AR
4454
IgM Patient 3 -180 mild
G14569AR
6735
IgA Patient 3 4 mild
G14569AR
2901
IgG Patient 3 4 mild
G14569AR
4766
IgM Patient 3 11 mild
G14569AR
8027
IgM Patient 3 4 mild
G14569AR
8558
IgA Patient 4 12 mild
G14569AR
406
IgG Patient 4 12 mild
G14569AR
84
IgM Patient 4 12 mild
G14569AR
99
IgA Patient 1 10 moderate
G14844CX
414
IgA Patient 1 22 moderate
G14844CX
389
IgA Patient 1 6 moderate
G14844CX
303
IgG Patient 1 10 moderate
G14844CX
27
IgG Patient 1 22 moderate
G14844CX
35
IgG Patient 1 6 moderate
G14844CX
24
IgM Patient 1 10 moderate
G14844CX
57
IgM Patient 1 22 moderate
G14844CX
174
IgM Patient 1 6 moderate
G14844CX
38
IgA Patient 2 15 mild
G14844CX
327
IgA Patient 2 24 mild
G14844CX
368
IgG Patient 2 15 mild
G14844CX
31
IgG Patient 2 24 mild
G14844CX
37
IgM Patient 2 15 mild
G14844CX
98
IgM Patient 2 24 mild
G14844CX
131

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024